文献速递血栓与止血

CD8+ T细胞克隆在免疫性血小板减少症中的作用

The role of CD8+ T-cell clones in immune thrombocytopenia.
PubMed 文献 · Blood · 2023-01-01

该研究采用免疫表型分析、T细胞受体(TCR)基因二代测序、单细胞RNA测序及功能性T细胞和血小板检测,比较成人慢性免疫性血小板减少症(ITP)患者与年龄匹配对照。发现ITP患者存在增多的多功能性终末分化效应记忆CD8+ T细胞(TEMRA),这些细胞在血小板计数下降时扩增且无生理性耗竭证据;TCR深度测序显示ITP患者存在扩增的T细胞克隆,克隆持续多年、在难治性疾病中更突出、血小板低时扩增。体外实验表明ITP患者CD8+ T细胞与自体血小板形成聚集体、释放干扰素γ并通过TCR介导的细胞毒性颗粒释放触发血小板活化和凋亡。

要点

  • 成人慢性ITP患者TEMRA型CD8+ T细胞增多,表达干扰素γ、肿瘤坏死因子α和颗粒酶B。
  • TEMRA细胞在血小板计数下降时扩增,且无生理性耗竭证据。
  • ITP患者存在持续多年的扩增T细胞克隆,难治性疾病中更突出,血小板低时扩增。

核心结论

  • 克隆扩增的CD8+ T细胞导致血小板活化和凋亡,提供了抗体非依赖的血小板破坏机制,提示靶向特定T细胞克隆可能成为难治性ITP患者的新治疗思路。

研究设计与样本

  • 研究采用多维方法探索细胞毒性CD8+ T细胞在ITP中的作用,使用免疫表型分析、T细胞受体(TCR)基因二代测序、单细胞RNA测序及功能性T细胞和血小板检测,比较ITP患者与年龄匹配对照。

主要发现

  • 成人慢性ITP患者具有增多的多功能性终末分化效应记忆CD8+ T细胞(CD45RA+CD62L-),表达细胞内干扰素γ、肿瘤坏死因子α和颗粒酶B,定义为TEMRA细胞。
  • TEMRA细胞在血小板计数下降时扩增,且无生理性耗竭证据。
  • TCR深度测序显示ITP患者存在扩增的T细胞克隆,克隆持续多年,在难治性疾病患者中更突出,并在血小板计数低时扩增。
  • CD8+ T细胞的单细胞RNA与TCR联合测序证实扩增的克隆为TEMRA细胞。
  • 体外模型系统中,ITP患者CD8+ T细胞与自体血小板形成聚集体,释放干扰素γ,并通过TCR介导的细胞毒性颗粒释放触发血小板活化和凋亡。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune thrombocytopenia (ITP) is traditionally considered an antibody-mediated disease. However, a number of features suggest alternative mechanisms of platelet destruction. In this study, we use a multidimensional approach to explore the role of cytotoxic CD8+ T cells in ITP. We characterized patients with ITP and compared them with age-matched controls using immunophenotyping, next-generation sequencing of T-cell receptor (TCR) genes, single-cell RNA sequencing, and functional T-cell and platelet assays. We found that adults with chronic ITP have increased polyfunctional, terminally differentiated effector memory CD8+ T cells (CD45RA+CD62L-) expressing intracellular interferon gamma, tumor necrosis factor α, and granzyme B, defining them as TEMRA cells. These TEMRA cells expand when the platelet count falls and show no evidence of physiological exhaustion. Deep sequencing of the TCR showed expanded T-cell clones in patients with ITP. T-cell clones persisted over many years, were more prominent in patients with refractory disease, and expanded when the platelet count was low. Combined single-cell RNA and TCR sequencing of CD8+ T cells confirmed that the expanded clones are TEMRA cells. Using in vitro model systems, we show that CD8+ T cells from patients with ITP form aggregates with autologous platelets, release interferon gamma, and trigger platelet activation and apoptosis via the TCR-mediated release of cytotoxic granules. These findings of clonally expanded CD8+ T cells causing platelet activation and apoptosis provide an antibody-independent mechanism of platelet destruction, indicating that targeting specific T-cell clones could be a novel therapeutic approach for patients with refractory ITP.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Malik A, Sayed AA, Han P, et al. The role of CD8+ T-cell clones in immune thrombocytopenia. Blood. 2023. PMID: 36749920. doi:10.1182/blood.2022018380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。